477 related articles for article (PubMed ID: 27127133)
1. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
[TBL] [Abstract][Full Text] [Related]
2. The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and beta-catenin, in prostate cancer.
Contreras HR; Ledezma RA; Vergara J; Cifuentes F; Barra C; Cabello P; Gallegos I; Morales B; Huidobro C; Castellón EA
Urol Oncol; 2010; 28(5):534-40. PubMed ID: 19450993
[TBL] [Abstract][Full Text] [Related]
3. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
[TBL] [Abstract][Full Text] [Related]
4. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
[TBL] [Abstract][Full Text] [Related]
5. Differential membranous E-cadherin expression, cell proliferation and O-GlcNAcylation between primary and metastatic nodal lesion in colorectal cancer.
Jang TJ
Pathol Res Pract; 2016 Feb; 212(2):113-9. PubMed ID: 26724145
[TBL] [Abstract][Full Text] [Related]
6. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin and E-cadherin tissue "content" as prognostic markers in left-side colorectal cancer.
Martinez NP; Kanno DT; Pereira JA; Cardinalli IA; Priolli DG
Cancer Biomark; 2010-2011; 8(3):129-35. PubMed ID: 22012768
[TBL] [Abstract][Full Text] [Related]
9. Expression of adhesion molecules and epithelial-mesenchymal transition factors in medullary carcinoma of the colorectum.
Takahashi S; Kohashi K; Yamamoto H; Hirahashi M; Kumagai R; Takizawa N; Nakamura K; Maehara Y; Tanaka M; Takayanagi R; Oda Y
Hum Pathol; 2015 Sep; 46(9):1257-66. PubMed ID: 26208847
[TBL] [Abstract][Full Text] [Related]
10. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of homeobox B-13 correlates with angiogenesis, aberrant expression of EMT markers, aggressive characteristics and poor prognosis in pancreatic carcinoma.
Zhai LL; Wu Y; Cai CY; Tang ZG
Int J Clin Exp Pathol; 2015; 8(6):6919-27. PubMed ID: 26261579
[TBL] [Abstract][Full Text] [Related]
13. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
[TBL] [Abstract][Full Text] [Related]
14. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
Gao ZH; Lu C; Wang ZN; Song YX; Zhu JL; Gao P; Sun JX; Chen XW; Wang MX; Dong YL; Xu HM
Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer.
Xu L; Jiang Y; Zheng J; Xie G; Li J; Shi L; Fan S
Hum Pathol; 2013 Jul; 44(7):1357-64. PubMed ID: 23375645
[TBL] [Abstract][Full Text] [Related]
17. PDLIM1 Stabilizes the E-Cadherin/β-Catenin Complex to Prevent Epithelial-Mesenchymal Transition and Metastatic Potential of Colorectal Cancer Cells.
Chen HN; Yuan K; Xie N; Wang K; Huang Z; Chen Y; Dou Q; Wu M; Nice EC; Zhou ZG; Huang C
Cancer Res; 2016 Mar; 76(5):1122-34. PubMed ID: 26701804
[TBL] [Abstract][Full Text] [Related]
18. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
[TBL] [Abstract][Full Text] [Related]
19. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
Yun JA; Kim SH; Hong HK; Yun SH; Kim HC; Chun HK; Cho YB; Lee WY
Oncology; 2014; 86(5-6):318-28. PubMed ID: 24924873
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
